| Company | Value | Change | %Change |
|---|
Zydus Wellness’ revenue from operations stood at ₹450.8 crore in the December 2024 quarter, rising 12.7% on a YoY basis. The figure was at ₹400.1 crore in the same quarter of the preceding fiscal year.
Opening marginally higher at ₹1859.55 apiece on the BSE on Tuesday, shares of Zydus Wellness rose as much as 4.6% to touch an intraday high of ₹1946.10. However, the stock could not sustain the early gains and tripped nearly 6% to a low of ₹1752.15 apiece on the BSE.
At the operating level, Zydus Wellness reported an EBITDA (Earnings before Interest, Tax, Depreciation, and Amortisation) of ₹14.8 crore in Q3 FY25, marking an uptick of 16.5% YoY compared to ₹12.7 crore in the year-ago period.
Its EBITDA margin rose marginally to 3.2% in the quarter under review from 3.1% in Q3 FY24. The company’s PAT margin made a sharp jump to 1.4% in the October to December 2024 period from 0.1% in the year-ago quarter.The company’s gross contribution grew 16.6% YoY to ₹226.3 crore in the December quarter from ₹194 crore in the same period last year. Its gross contribution margin also gained 2 basis points (bps) YoY to 47.7%.
Zydus Wellness witnessed a steady growth in rural consumption in both food and non-food categories. Its gross margin growth in the quarter was driven by strategic hedging, favourable product mix and calibrated pricing.
The company completed the acquisition of 100% equity share capital of Naturell (India) in Q3 FY25 and continued to support the brand through digital media, e-commerce activation and consumer engagement at marathons and other events.
Shares of Zydus Wellness were seen trading 5.03% lower at ₹1,766 per piece on the BSE at 1:23 pm on February 4.
(Edited by : Ajay Vaishnav)
